Wedbush Securities’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,611
| Closed | -$274K | – | 1009 |
|
|
2020
Q3 | $274K | Buy |
6,611
+191
| +3% | +$7.92K | 0.03% | 652 |
|
|
2020
Q2 | $308K | Buy |
+6,420
| New | +$308K | 0.03% | 596 |
|
|
2020
Q1 | – | Sell |
-2,990
| Closed | -$371K | – | 1029 |
|
|
2019
Q4 | $371K | Sell |
2,990
-4,946
| -62% | -$614K | 0.03% | 587 |
|
|
2019
Q3 | $527K | Buy |
7,936
+957
| +14% | +$63.6K | 0.05% | 427 |
|
|
2019
Q2 | $555K | Buy |
6,979
+1,790
| +34% | +$142K | 0.06% | 389 |
|
|
2019
Q1 | $580K | Buy |
5,189
+635
| +14% | +$71K | 0.06% | 363 |
|
|
2018
Q4 | $459K | Buy |
4,554
+1,080
| +31% | +$109K | 0.06% | 386 |
|
|
2018
Q3 | $439K | Buy |
3,474
+357
| +11% | +$45.1K | 0.05% | 447 |
|
|
2018
Q2 | $262K | Sell |
3,117
-2,605
| -46% | -$219K | 0.03% | 609 |
|
|
2018
Q1 | $352K | Buy |
5,722
+50
| +0.9% | +$3.08K | 0.05% | 475 |
|
|
2017
Q4 | $331K | Buy |
+5,672
| New | +$331K | 0.04% | 510 |
|
|
2017
Q3 | – | Sell |
-2,395
| Closed | -$290K | – | 882 |
|
|
2017
Q2 | $290K | Buy |
2,395
+310
| +15% | +$37.5K | 0.04% | 556 |
|
|
2017
Q1 | $236K | Sell |
2,085
-285
| -12% | -$32.3K | 0.03% | 628 |
|
|
2016
Q4 | $258K | Buy |
2,370
+75
| +3% | +$8.17K | 0.04% | 566 |
|
|
2016
Q3 | $378K | Buy |
2,295
+35
| +2% | +$5.77K | 0.06% | 421 |
|
|
2016
Q2 | $322K | Buy |
2,260
+40
| +2% | +$5.7K | 0.05% | 431 |
|
|
2016
Q1 | $285K | Buy |
2,220
+125
| +6% | +$16K | 0.05% | 447 |
|
|
2015
Q4 | $313K | Sell |
2,095
-65
| -3% | -$9.71K | 0.06% | 387 |
|
|
2015
Q3 | $358K | Sell |
2,160
-8
| -0.4% | -$1.33K | 0.07% | 314 |
|
|
2015
Q2 | $523K | Buy |
2,168
+28
| +1% | +$6.76K | 0.1% | 248 |
|
|
2015
Q1 | $604K | Sell |
2,140
-75
| -3% | -$21.2K | 0.1% | 224 |
|
|
2014
Q4 | $346K | Buy |
+2,215
| New | +$346K | 0.05% | 359 |
|